Persistence of dengue serotype 2 viral RNA in blood cells of a returned traveler with dengue fever

• Published in: Travel Medicine and Infectious Disease
• Main Authors: Rebecca S.B. Fischer, Samuel Vilchez, Shannon E. Ronca, Rebecca Kairis, Allison Lino, Adrianna Maliga, Sarah M. Gunter, Kristy O. Murray
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier 2024
• Subjects: Dengue virus (DENV); Serotype 2; Arbovirus infection; Viral RNA persistence; Dengue fever; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic
• Online Access: https://doi.org/10.1016/j.tmaid.2024.102699; https://doaj.org/article/84ca5d74b529443cbe86bc44e5120ebc

Dengue virus (DENV) is one of the most significant vector-borne pathogens worldwide. In this report, we describe clinical features and laboratory detection of dengue in a 45-year-old traveler to Nicaragua on return home to the United States in 2019. Clinical presentation was mild, with rash, headache, and fatigue, with only low-grade transient fever. Infection dynamics were documented by serology and PCR of serially collected body fluids. DENV serotype 2 was detected in whole blood 1 day after symptoms emerged, with viral RNA isolated to the red cell fraction, and remained detectable through day 89. DENV-2 RNA was detected in serum only on day 4, and IgM was undetectable on day 4 but evident by day 13. Viral RNA was also detected in urine. This report of DENV-2 RNA persistence in blood cells but only transient appearance in serum, supports the potential diagnostic value of whole blood over serum for PCR and opportunity of an expanded testing window. Informed testing approaches can improve diagnostic accuracy and inform strategies that preserve individual and public health.